FDA OKs Label Change for Victoza Showing Efficacy Boost Over Januvia
The FDA has approved an update to the U.S. label for Novo Nordisk’s diabetes drug Victoza to include data showing superior blood sugar and weight control compared with Merck’s Januvia.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.